WuShuo has learned that Hyperliquid Strategies Inc. has submitted an S-1 registration statement to the U.S. Securities and Exchange Commission. After completing a dual merger transaction with Sonnet BioTherapeutics Holdings and Rorschach I LLC, the company plans to issue up to 160 million common shares through a committed equity financing agreement (Facility) signed with Chardan Capital Markets, raising up to $1 billion. The funds raised will be used for general corporate purposes, including the potential purchase of HYPE Token. https://www.(wublock123.com)/index.php?m=content&c=index&a=show&catid=6&id=50652